Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
28
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Younis Husam | Chief Scientific Officer | 4 | $0 | $0 | 2026-09-18 |
| Hoyos Rocio Martin | Chief Strategy Officer | 4 | $0 | $0 | 2026-09-18 |
| Winslow Brendan R. | Chief Financial Officer | 4 | $0 | $0 | 2026-09-18 |
| Kenney Stephanie | See Remarks | 4 | $0 | $0 | 2026-09-18 |
| Gallagher Kathleen P. | See Remarks, Director | 33 | $0 | $1.22M | 2026-09-18 |
| Flanagan W. Michael | Director | 51 | $0 | $13.50M | 2026-09-18 |
| Hughes Steven George | Chief Medical Officer | 40 | $0 | $4.86M | 2026-09-18 |
| Boyce Sarah | President and CEO | 86 | $0 | $33.09M | 2026-09-18 |
| Skerjanec Simona | Director | 4 | $0 | $0 | 2026-02-27 |
| WILSON TROY EDWARD | Director | 31 | $0 | $5.75M | 2026-02-27 |
| BOESS CARSTEN | Director | 7 | $0 | $0 | 2026-02-27 |
| McCarthy Teresa | Chief Human Resources Officer | 45 | $0 | $8.20M | 2026-01-21 |
| MacLean Michael F | Chief Financial Officer | 40 | $0 | $15.13M | 2026-01-21 |
| LEVIN ARTHUR A | Director | 102 | $0 | $17.37M | 2026-01-21 |
| Calderaro Charles III | Chief Technical Officer | 5 | $0 | $269.2K | 2026-01-07 |
| Moriarty John B | Chief Legal Officer | 8 | $0 | $252.8K | 2026-01-07 |
| Mosbrooker Eric | Director | 18 | $0 | $6.37M | 2025-12-17 |
| Kim Jean Jinsun | Director | 6 | $0 | $0 | 2025-06-10 |
| Thompson Tamar | Director | 9 | $0 | $1.35M | 2025-06-10 |
| Henig Noreen | Director | 6 | $0 | $0 | 2025-06-10 |
| Kaye Edward M. MD | Director | 6 | $0 | $0 | 2025-06-10 |
| WONG RODERICK | MP and CIO | 3 | $14.40M | $0 | 2021-08-04 |
| Kim Jae B. | Chief Medical Officer | 2 | $0 | $0 | 2021-02-02 |
| Baroldi Joseph | Chief Operating Officer | 1 | $0 | $0 | 2021-02-02 |
| ELI LILLY & Co | 10% Owner | 2 | $0 | $0 | 2020-06-16 |
| Cormorant Private Healthcare Fund II, LP | 10% Owner | 3 | $5.40M | $0 | 2020-06-16 |
| Alexandria Venture Investments, LLC | 10% Owner | 4 | $0 | $0 | 2020-06-16 |
| RTW INVESTMENTS, LP | 10% Owner | 3 | $17.10M | $0 | 2020-06-16 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Hoyos Rocio Martin | Chief Strategy Officer | F Tax w/h | 2026-09-18 | 2026-09-22 | 8,320 | $8.95 | $74.5K | 38,340 | SEC↗ |
| Winslow Brendan R. | Chief Financial Officer | F Tax w/h | 2026-09-18 | 2026-09-22 | 6,742 | $8.95 | $60.3K | 36,859 | SEC↗ |
| Gallagher Kathleen P. | See Remarks | F Tax w/h | 2026-09-18 | 2026-09-22 | 11,632 | $8.95 | $104.1K | 119,729 | SEC↗ |
| Kenney Stephanie | See Remarks | F Tax w/h | 2026-09-18 | 2026-09-22 | 2,375 | $8.95 | $21.3K | 33,085 | SEC↗ |
| Boyce Sarah | Director | F Tax w/h | 2026-09-18 | 2026-09-22 | 126,418 | $8.95 | $1.13M | 138,668 | SEC↗ |
| Flanagan W. Michael | Director | F Tax w/h | 2026-09-18 | 2026-09-22 | 22,812 | $8.95 | $204.2K | 31,974 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | F Tax w/h | 2026-09-18 | 2026-09-22 | 21,459 | $8.95 | $192.1K | 51,638 | SEC↗ |
| Younis Husam | Chief Scientific Officer | F Tax w/h | 2026-09-18 | 2026-09-22 | 11,216 | $8.95 | $100.4K | 41,441 | SEC↗ |
| Younis Husam | Chief Scientific Officer | F Tax w/h | 2026-09-18 | 2026-09-22 | 11,216 | $8.95 | $100.4K | 41,441 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | F Tax w/h | 2026-09-18 | 2026-09-22 | 21,459 | $8.95 | $192.1K | 51,638 | SEC↗ |
| Flanagan W. Michael | Director | F Tax w/h | 2026-09-18 | 2026-09-22 | 22,812 | $8.95 | $204.2K | 31,974 | SEC↗ |
| Boyce Sarah | Director | F Tax w/h | 2026-09-18 | 2026-09-22 | 126,418 | $8.95 | $1.13M | 138,668 | SEC↗ |
| Kenney Stephanie | See Remarks | F Tax w/h | 2026-09-18 | 2026-09-22 | 2,375 | $8.95 | $21.3K | 33,085 | SEC↗ |
| Gallagher Kathleen P. | See Remarks, Director | F Tax w/h | 2026-09-18 | 2026-09-22 | 11,632 | $8.95 | $104.1K | 119,729 | SEC↗ |
| Winslow Brendan R. | Chief Financial Officer | F Tax w/h | 2026-09-18 | 2026-09-22 | 6,742 | $8.95 | $60.3K | 36,859 | SEC↗ |
| Hoyos Rocio Martin | Chief Strategy Officer | F Tax w/h | 2026-09-18 | 2026-09-22 | 8,320 | $8.95 | $74.5K | 38,340 | SEC↗ |
| Younis Husam | Chief Scientific Officer | A Award deriv | 2026-04-20 | 2026-04-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hoyos Rocio Martin | Chief Strategy Officer | A Award deriv | 2026-04-20 | 2026-04-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Gallagher Kathleen P. | See Remarks | A Award deriv | 2026-04-20 | 2026-04-22 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Winslow Brendan R. | Chief Financial Officer | A Award deriv | 2026-04-20 | 2026-04-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | A Award deriv | 2026-04-20 | 2026-04-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Kenney Stephanie | See Remarks | A Award deriv | 2026-04-20 | 2026-04-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Younis Husam | Chief Scientific Officer | A Award | 2026-04-20 | 2026-04-22 | 30,000 | — | $0 | 52,657 | SEC↗ |
| Hoyos Rocio Martin | Chief Strategy Officer | A Award | 2026-04-20 | 2026-04-22 | 30,000 | — | $0 | 46,660 | SEC↗ |
| Gallagher Kathleen P. | See Remarks | A Award | 2026-04-20 | 2026-04-22 | 102,500 | — | $0 | 131,361 | SEC↗ |
| Winslow Brendan R. | Chief Financial Officer | A Award | 2026-04-20 | 2026-04-22 | 30,000 | — | $0 | 43,601 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | A Award | 2026-04-20 | 2026-04-22 | 30,000 | — | $0 | 73,097 | SEC↗ |
| Kenney Stephanie | See Remarks | A Award | 2026-04-20 | 2026-04-22 | 30,000 | — | $0 | 35,460 | SEC↗ |
| Skerjanec Simona | Director | A Award deriv | 2026-02-27 | 2026-03-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| WILSON TROY EDWARD | Director | A Award deriv | 2026-02-27 | 2026-03-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Flanagan W. Michael | Director | A Award deriv | 2026-02-27 | 2026-03-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BOESS CARSTEN | Director | A Award deriv | 2026-02-27 | 2026-03-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Boyce Sarah | Director | A Award deriv | 2026-02-27 | 2026-03-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2026-01-21 | 2026-01-23 | 1,453 | $72.45 | $105.3K | 113,938 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2026-01-21 | 2026-01-23 | 1,476 | $72.45 | $106.9K | 115,391 | SEC↗ |
| LEVIN ARTHUR A | Director | S Sale | 2026-01-21 | 2026-01-23 | 1,758 | $72.45 | $127.4K | 16,562 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2026-01-21 | 2026-01-23 | 1,807 | $72.45 | $130.9K | 62,025 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2026-01-21 | 2026-01-23 | 2,735 | $72.45 | $198.2K | 59,290 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | S Sale | 2026-01-21 | 2026-01-23 | 3,976 | $72.45 | $288.1K | 87,651 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | S Sale | 2026-01-21 | 2026-01-23 | 2,558 | $72.45 | $185.3K | 85,093 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2026-01-21 | 2026-01-23 | 7,993 | $72.45 | $579.1K | 269,007 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2026-01-21 | 2026-01-23 | 6,394 | $72.45 | $463.2K | 277,000 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2026-01-21 | 2026-01-23 | 2,878 | $72.45 | $208.5K | 31,599 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2026-01-21 | 2026-01-23 | 2,017 | $72.45 | $146.1K | 34,477 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | S Sale | 2026-01-07 | 2026-01-09 | 2,373 | $72.23 | $171.4K | 91,627 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2026-01-07 | 2026-01-09 | 2,373 | $72.23 | $171.4K | 36,494 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2026-01-07 | 2026-01-09 | 1,974 | $72.23 | $142.6K | 63,832 | SEC↗ |
| Moriarty John B | Chief Legal Officer | S Sale | 2026-01-07 | 2026-01-09 | 2,374 | $72.23 | $171.5K | 74,557 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2026-01-07 | 2026-01-09 | 1,965 | $72.23 | $141.9K | 116,867 | SEC↗ |
| Calderaro Charles III | Chief Technical Officer | S Sale | 2026-01-07 | 2026-01-09 | 3,727 | $72.23 | $269.2K | 49,797 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2026-01-07 | 2026-01-09 | 8,576 | $72.23 | $619.4K | 283,394 | SEC↗ |
| LEVIN ARTHUR A | Director | G Gift | 2025-12-19 | 2025-12-22 | 1,330 | — | $0 | 18,320 | SEC↗ |
| Boyce Sarah | President and CEO | G Gift | 2025-12-18 | 2025-12-19 | 29,159 | — | $0 | 291,970 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | F Tax w/h | 2025-12-17 | 2025-12-19 | 17,298 | $71.87 | $1.24M | 118,832 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | A Award | 2025-12-17 | 2025-12-19 | 39,000 | — | $0 | 136,130 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | F Tax w/h | 2025-12-17 | 2025-12-19 | 33,336 | $71.87 | $2.40M | 88,868 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | F Tax w/h | 2025-12-17 | 2025-12-19 | 8,030 | $71.87 | $577.1K | 80,838 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | A Award | 2025-12-17 | 2025-12-19 | 72,000 | — | $0 | 122,204 | SEC↗ |
| Moriarty John B | Chief Legal Officer | A Award | 2025-12-17 | 2025-12-19 | 56,000 | — | $0 | 103,755 | SEC↗ |
| Moriarty John B | Chief Legal Officer | F Tax w/h | 2025-12-17 | 2025-12-19 | 26,824 | $71.87 | $1.93M | 76,931 | SEC↗ |
| Boyce Sarah | President and CEO | F Tax w/h | 2025-12-17 | 2025-12-19 | 15,742 | $71.87 | $1.13M | 321,129 | SEC↗ |
| Boyce Sarah | President and CEO | A Award | 2025-12-17 | 2025-12-19 | 31,000 | — | $0 | 336,871 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | F Tax w/h | 2025-12-17 | 2025-12-19 | 11,426 | $71.87 | $821.2K | 79,010 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | F Tax w/h | 2025-12-17 | 2025-12-19 | 36,564 | $71.87 | $2.63M | 90,436 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | A Award | 2025-12-17 | 2025-12-19 | 72,000 | — | $0 | 127,000 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | A Award | 2025-12-17 | 2025-12-19 | 27,500 | — | $0 | 107,695 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | F Tax w/h | 2025-12-17 | 2025-12-19 | 13,695 | $71.87 | $984.3K | 94,000 | SEC↗ |
| Calderaro Charles III | Chief Technical Officer | F Tax w/h | 2025-12-17 | 2025-12-19 | 9,726 | $71.87 | $699.0K | 53,524 | SEC↗ |
| Calderaro Charles III | Chief Technical Officer | A Award | 2025-12-17 | 2025-12-19 | 23,250 | — | $0 | 63,250 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise deriv | 2025-10-22 | 2025-10-24 | 2,209 | — | $0 | 68,458 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise | 2025-10-22 | 2025-10-24 | 2,209 | $10.16 | $22.4K | 41,076 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-10-22 | 2025-10-24 | 2,209 | $47.54 | $105.0K | 38,867 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise deriv | 2025-10-15 | 2025-10-17 | 20,000 | — | $0 | 65,000 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise | 2025-10-15 | 2025-10-17 | 20,000 | $22.34 | $446.8K | 117,130 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2025-10-15 | 2025-10-17 | 20,000 | $50.15 | $1.00M | 97,130 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | M Exercise deriv | 2025-10-03 | 2025-10-07 | 6,562 | — | $0 | 177,188 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | M Exercise | 2025-10-03 | 2025-10-07 | 6,562 | $9.05 | $59.4K | 61,562 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | S Sale | 2025-10-03 | 2025-10-07 | 6,562 | $45.38 | $297.8K | 55,000 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise deriv | 2025-09-22 | 2025-09-23 | 2,208 | — | $0 | 70,667 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise | 2025-09-22 | 2025-09-23 | 2,208 | $10.16 | $22.4K | 41,075 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-09-22 | 2025-09-23 | 2,208 | $40.58 | $89.6K | 38,867 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise deriv | 2025-09-15 | 2025-09-17 | 1,542 | — | $0 | 49,333 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise deriv | 2025-09-15 | 2025-09-17 | 15,000 | — | $0 | 85,000 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise | 2025-09-15 | 2025-09-17 | 1,542 | $6.57 | $10.1K | 40,409 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-09-15 | 2025-09-17 | 1,542 | $45.41 | $70.0K | 38,867 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2025-09-15 | 2025-09-17 | 15,000 | $41.41 | $621.1K | 97,130 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise | 2025-09-15 | 2025-09-17 | 15,000 | $22.34 | $335.1K | 112,130 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | M Exercise deriv | 2025-09-11 | 2025-09-12 | 20,000 | — | $0 | 76,500 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | M Exercise | 2025-09-11 | 2025-09-12 | 20,000 | $14.22 | $284.4K | 100,195 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | S Sale | 2025-09-11 | 2025-09-12 | 20,000 | $38.94 | $778.8K | 80,195 | SEC↗ |
| Boyce Sarah | President and CEO | M Exercise deriv | 2025-09-05 | 2025-09-05 | 50,000 | — | $0 | 1,022,015 | SEC↗ |
| WILSON TROY EDWARD | Director | M Exercise deriv | 2025-09-05 | 2025-09-09 | 14,500 | — | $0 | 0 | SEC↗ |
| Boyce Sarah | President and CEO | M Exercise | 2025-09-05 | 2025-09-05 | 50,000 | $1.24 | $62.0K | 355,871 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2025-09-05 | 2025-09-05 | 50,000 | $49.95 | $2.50M | 305,871 | SEC↗ |
| WILSON TROY EDWARD | Director | S Sale | 2025-09-05 | 2025-09-09 | 14,500 | $50.00 | $725.0K | 69,425 | SEC↗ |
| WILSON TROY EDWARD | Director | S Sale | 2025-09-05 | 2025-09-09 | 15,000 | $50.00 | $750.0K | 54,425 | SEC↗ |
| WILSON TROY EDWARD | Director | M Exercise | 2025-09-05 | 2025-09-09 | 14,500 | $12.48 | $181.0K | 83,925 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | M Exercise deriv | 2025-09-03 | 2025-09-05 | 6,563 | — | $0 | 183,750 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | S Sale | 2025-09-03 | 2025-09-05 | 6,563 | $47.07 | $308.9K | 55,000 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | M Exercise | 2025-09-03 | 2025-09-05 | 6,563 | $9.05 | $59.4K | 61,563 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-09-02 | 2025-09-02 | 188 | $47.42 | $8.9K | 50,204 | SEC↗ |
| Boyce Sarah | President and CEO | M Exercise deriv | 2025-08-28 | 2025-08-29 | 25,000 | — | $0 | 1,072,015 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2025-08-28 | 2025-08-29 | 25,000 | $49.39 | $1.23M | 305,871 | SEC↗ |
| Boyce Sarah | President and CEO | M Exercise | 2025-08-28 | 2025-08-29 | 25,000 | $1.24 | $31.0K | 330,871 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise deriv | 2025-08-22 | 2025-08-22 | 2,208 | — | $0 | 72,875 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-08-22 | 2025-08-22 | 2,208 | $46.40 | $102.5K | 38,867 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise | 2025-08-22 | 2025-08-22 | 2,208 | $10.16 | $22.4K | 41,075 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise deriv | 2025-08-15 | 2025-08-15 | 10,000 | — | $0 | 100,000 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2025-08-15 | 2025-08-15 | 10,000 | $46.56 | $465.6K | 97,130 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise | 2025-08-15 | 2025-08-15 | 10,000 | $22.34 | $223.4K | 107,130 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise deriv | 2025-08-13 | 2025-08-15 | 1,542 | — | $0 | 50,875 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-08-13 | 2025-08-15 | 1,542 | $46.66 | $71.9K | 38,867 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise | 2025-08-13 | 2025-08-15 | 1,542 | $6.57 | $10.1K | 40,409 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise deriv | 2025-08-06 | 2025-08-08 | 17,667 | — | $0 | 75,083 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise deriv | 2025-08-06 | 2025-08-08 | 6,167 | — | $0 | 74,000 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise deriv | 2025-08-06 | 2025-08-08 | 12,334 | — | $0 | 52,417 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise deriv | 2025-08-06 | 2025-08-08 | 11,283 | — | $0 | 73,342 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise deriv | 2025-08-06 | 2025-08-08 | 107,500 | — | $0 | 12,500 | SEC↗ |
| WILSON TROY EDWARD | Director | M Exercise deriv | 2025-08-06 | 2025-08-08 | 22,000 | — | $0 | 0 | SEC↗ |
| WILSON TROY EDWARD | Director | M Exercise deriv | 2025-08-06 | 2025-08-08 | 7,500 | — | $0 | 14,500 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | M Exercise deriv | 2025-08-06 | 2025-08-08 | 124,687 | — | $0 | 190,313 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise | 2025-08-06 | 2025-08-08 | 17,667 | $10.16 | $179.5K | 90,517 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-08-06 | 2025-08-08 | 6,167 | $42.74 | $263.6K | 72,850 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise | 2025-08-06 | 2025-08-08 | 6,167 | $22.47 | $138.6K | 79,017 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-08-06 | 2025-08-08 | 12,334 | $42.74 | $527.2K | 72,850 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise | 2025-08-06 | 2025-08-08 | 12,334 | $6.57 | $81.0K | 85,184 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-08-06 | 2025-08-08 | 11,283 | $42.74 | $482.2K | 72,850 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | M Exercise | 2025-08-06 | 2025-08-08 | 11,283 | $15.96 | $180.1K | 84,133 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-08-06 | 2025-08-08 | 33,983 | $42.74 | $1.45M | 38,867 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-08-06 | 2025-08-08 | 17,667 | $42.74 | $755.1K | 72,850 | SEC↗ |
| LEVIN ARTHUR A | Director | S Sale | 2025-08-06 | 2025-08-08 | 107,500 | $47.62 | $5.12M | 19,650 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise | 2025-08-06 | 2025-08-08 | 107,500 | $22.34 | $2.40M | 127,150 | SEC↗ |
| WILSON TROY EDWARD | Director | S Sale | 2025-08-06 | 2025-08-08 | 17,777 | $45.00 | $800.0K | 17,776 | SEC↗ |
| WILSON TROY EDWARD | Director | M Exercise | 2025-08-06 | 2025-08-08 | 22,000 | $12.03 | $264.7K | 91,425 | SEC↗ |
| WILSON TROY EDWARD | Director | S Sale | 2025-08-06 | 2025-08-08 | 17,777 | $45.00 | $800.0K | 17,776 | SEC↗ |
| WILSON TROY EDWARD | Director | S Sale | 2025-08-06 | 2025-08-08 | 22,000 | $45.00 | $990.0K | 69,425 | SEC↗ |
| WILSON TROY EDWARD | Director | M Exercise | 2025-08-06 | 2025-08-08 | 7,500 | $12.48 | $93.6K | 76,925 | SEC↗ |
| WILSON TROY EDWARD | Director | S Sale | 2025-08-06 | 2025-08-08 | 7,500 | $45.00 | $337.5K | 69,425 | SEC↗ |
| WILSON TROY EDWARD | Director | S Sale | 2025-08-06 | 2025-08-08 | 15,000 | $45.00 | $675.0K | 285,000 | SEC↗ |
| WILSON TROY EDWARD | Director | S Sale | 2025-08-06 | 2025-08-08 | 15,000 | $45.00 | $675.0K | 285,000 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | S Sale | 2025-08-06 | 2025-08-08 | 6,120 | $44.06 | $269.6K | 55,000 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | S Sale | 2025-08-06 | 2025-08-08 | 124,687 | $44.06 | $5.49M | 61,120 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | M Exercise | 2025-08-06 | 2025-08-08 | 124,687 | $9.05 | $1.13M | 185,807 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2025-08-06 | 2025-08-15 | 30,914 | $42.73 | $1.32M | 65,806 | SEC↗ |
| Moriarty John B | Chief Legal Officer | S Sale | 2025-08-04 | 2025-08-05 | 2,245 | $36.21 | $81.3K | 47,755 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-06-17 | 2025-06-18 | 911 | $30.24 | $27.5K | 50,392 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | M Exercise deriv | 2025-06-11 | 2025-06-12 | 20,000 | — | $0 | 96,500 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | M Exercise | 2025-06-11 | 2025-06-12 | 20,000 | $14.22 | $284.4K | 100,195 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | S Sale | 2025-06-11 | 2025-06-12 | 20,000 | $32.88 | $657.6K | 80,195 | SEC↗ |
| Kim Jean Jinsun | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| Thompson Tamar | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| WILSON TROY EDWARD | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| Skerjanec Simona | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| LEVIN ARTHUR A | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| Kaye Edward M. MD | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| BOESS CARSTEN | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| Henig Noreen | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| Kim Jean Jinsun | Director | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 6,692 | SEC↗ |
| Thompson Tamar | Director | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 6,692 | SEC↗ |
| WILSON TROY EDWARD | Director | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 69,425 | SEC↗ |
| Skerjanec Simona | Director | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 6,692 | SEC↗ |
| LEVIN ARTHUR A | Director | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 19,650 | SEC↗ |
| Kaye Edward M. MD | Director | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 6,692 | SEC↗ |
| BOESS CARSTEN | Director | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 6,692 | SEC↗ |
| Henig Noreen | Director | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 6,692 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise deriv | 2025-06-02 | 2025-06-04 | 5,875 | — | $0 | 22,596 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise | 2025-06-02 | 2025-06-04 | 5,875 | $16.65 | $97.8K | 56,429 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-06-02 | 2025-06-04 | 5,875 | $32.48 | $190.8K | 50,554 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise deriv | 2025-05-01 | 2025-05-02 | 5,875 | — | $0 | 28,471 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise | 2025-05-01 | 2025-05-02 | 5,875 | $16.65 | $97.8K | 56,429 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-05-01 | 2025-05-02 | 5,875 | $32.40 | $190.3K | 50,554 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise deriv | 2025-04-01 | 2025-04-03 | 5,546 | — | $0 | 13,829 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise deriv | 2025-04-01 | 2025-04-03 | 329 | — | $0 | 34,346 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise | 2025-04-01 | 2025-04-03 | 329 | $16.65 | $5.5K | 50,883 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-04-01 | 2025-04-03 | 329 | $27.83 | $9.2K | 50,554 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-04-01 | 2025-04-03 | 5,546 | $27.83 | $154.3K | 50,554 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise | 2025-04-01 | 2025-04-03 | 5,546 | $14.70 | $81.5K | 56,100 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2025-03-20 | 2025-03-21 | 7,778 | $31.06 | $241.6K | 97,130 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2025-03-20 | 2025-03-21 | 7,935 | $31.06 | $246.5K | 96,720 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | S Sale | 2025-03-20 | 2025-03-21 | 11,780 | $31.06 | $365.9K | 80,195 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2025-03-20 | 2025-03-21 | 31,540 | $31.06 | $979.6K | 305,871 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-03-20 | 2025-03-21 | 9,578 | $31.06 | $297.5K | 72,850 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | M Exercise deriv | 2025-03-11 | 2025-03-12 | 20,000 | — | $0 | 116,500 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | S Sale | 2025-03-11 | 2025-03-12 | 20,000 | $30.13 | $602.6K | 91,975 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | M Exercise | 2025-03-11 | 2025-03-12 | 20,000 | $14.22 | $284.4K | 111,975 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise deriv | 2025-03-03 | 2025-03-04 | 5,875 | — | $0 | 19,375 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise | 2025-03-03 | 2025-03-04 | 5,875 | $14.70 | $86.4K | 56,429 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-03-03 | 2025-03-04 | 5,875 | $29.41 | $172.8K | 50,554 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise deriv | 2025-02-03 | 2025-02-05 | 5,875 | — | $0 | 34,675 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-02-03 | 2025-02-05 | 5,875 | $32.16 | $188.9K | 50,554 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | M Exercise | 2025-02-03 | 2025-02-05 | 5,875 | $16.65 | $97.8K | 56,429 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-01-22 | 2025-01-23 | 5,629 | $30.16 | $169.8K | 50,554 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-01-21 | 2025-01-23 | 1,915 | $28.60 | $54.8K | 84,460 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2025-01-21 | 2025-01-23 | 2,032 | $28.59 | $58.1K | 82,428 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-01-21 | 2025-01-23 | 670 | $28.60 | $19.2K | 58,000 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-01-21 | 2025-01-23 | 1,817 | $28.59 | $51.9K | 56,183 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | S Sale | 2025-01-21 | 2025-01-23 | 1,295 | $28.59 | $37.0K | 58,670 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2025-01-21 | 2025-01-23 | 4,738 | $28.59 | $135.5K | 343,070 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2025-01-21 | 2025-01-23 | 5,659 | $28.59 | $161.8K | 337,411 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | S Sale | 2025-01-21 | 2025-01-23 | 3,860 | $28.60 | $110.4K | 93,787 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | S Sale | 2025-01-21 | 2025-01-23 | 1,812 | $28.59 | $51.8K | 91,975 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2025-01-21 | 2025-01-23 | 1,738 | $28.59 | $49.7K | 106,129 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2025-01-21 | 2025-01-23 | 1,221 | $28.60 | $34.9K | 104,908 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2025-01-21 | 2025-01-23 | 1,665 | $28.59 | $47.6K | 104,655 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2025-01-21 | 2025-01-23 | 1,622 | $28.59 | $46.4K | 106,320 | SEC↗ |
| LEVIN ARTHUR A | Director | S Sale | 2025-01-21 | 2025-01-23 | 1,872 | $28.60 | $53.5K | 12,958 | SEC↗ |
| Calderaro Charles III | Chief Technical Officer | A Award deriv | 2025-01-06 | 2025-01-08 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Boyce Sarah | President and CEO | A Award deriv | 2025-01-06 | 2025-01-08 | 165,000 | — | $0 | 165,000 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Moriarty John B | Chief Legal Officer | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Calderaro Charles III | Chief Technical Officer | A Award | 2025-01-06 | 2025-01-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Mosbrooker Eric | Chief Commercial Officer | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 61,120 | SEC↗ |
| Gallagher Kathleen P. | Chief Program Officer | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 59,965 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 86,375 | SEC↗ |
| Boyce Sarah | President and CEO | A Award | 2025-01-06 | 2025-01-08 | 82,500 | — | $0 | 347,808 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 107,942 | SEC↗ |
| Moriarty John B | Chief Legal Officer | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 50,000 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 107,867 | SEC↗ |
| Flanagan W. Michael | Chief Scientific Officer | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 97,647 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2024-12-18 | 2024-12-19 | 11,151 | $32.66 | $364.2K | 82,867 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2024-12-18 | 2024-12-19 | 31,855 | $32.66 | $1.04M | 265,308 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2024-12-18 | 2024-12-19 | 11,151 | $32.66 | $364.2K | 82,942 | SEC↗ |
| Flanagan W. Michael | CSTO | S Sale | 2024-12-18 | 2024-12-19 | 12,742 | $32.66 | $416.2K | 72,647 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise deriv | 2024-12-16 | 2024-12-18 | 25,000 | — | $0 | 57,500 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2024-12-16 | 2024-12-18 | 25,000 | $33.26 | $831.5K | 94,018 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise | 2024-12-16 | 2024-12-18 | 25,000 | $14.22 | $355.5K | 119,018 | SEC↗ |
| Flanagan W. Michael | CSTO | M Exercise deriv | 2024-12-11 | 2024-12-13 | 24,000 | — | $0 | 86,000 | SEC↗ |
| Flanagan W. Michael | CSTO | M Exercise | 2024-12-11 | 2024-12-13 | 24,000 | $22.47 | $539.3K | 109,389 | SEC↗ |
| Flanagan W. Michael | CSTO | S Sale | 2024-12-11 | 2024-12-13 | 24,000 | $35.77 | $858.5K | 85,389 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise deriv | 2024-11-19 | 2024-11-20 | 3,323 | — | $0 | 0 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise | 2024-11-19 | 2024-11-20 | 3,323 | $1.24 | $4.1K | 18,153 | SEC↗ |
| LEVIN ARTHUR A | Director | S Sale | 2024-11-19 | 2024-11-20 | 3,323 | $42.12 | $140.0K | 14,830 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise deriv | 2024-11-18 | 2024-11-20 | 25,000 | — | $0 | 82,500 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise | 2024-11-18 | 2024-11-20 | 25,000 | $14.22 | $355.5K | 119,018 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2024-11-18 | 2024-11-20 | 25,000 | $41.14 | $1.03M | 94,018 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | M Exercise deriv | 2024-11-06 | 2024-11-08 | 65,182 | — | $0 | 0 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | M Exercise deriv | 2024-11-06 | 2024-11-08 | 13,875 | — | $0 | 60,125 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2024-11-06 | 2024-11-08 | 13,875 | $45.33 | $629.0K | 94,093 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2024-11-06 | 2024-11-08 | 27,262 | $46.22 | $1.26M | 94,093 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | M Exercise | 2024-11-06 | 2024-11-08 | 65,182 | $8.82 | $574.9K | 159,275 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2024-11-06 | 2024-11-08 | 65,182 | $45.33 | $2.95M | 94,093 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | M Exercise | 2024-11-06 | 2024-11-08 | 13,875 | $6.57 | $91.2K | 107,968 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise deriv | 2024-10-21 | 2024-10-23 | 5,000 | — | $0 | 3,323 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise | 2024-10-21 | 2024-10-23 | 5,000 | $1.24 | $6.2K | 19,830 | SEC↗ |
| LEVIN ARTHUR A | Director | S Sale | 2024-10-21 | 2024-10-23 | 5,000 | $46.63 | $233.2K | 14,830 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise deriv | 2024-10-16 | 2024-10-17 | 25,000 | — | $0 | 107,500 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise | 2024-10-16 | 2024-10-17 | 25,000 | $14.22 | $355.5K | 119,018 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2024-10-16 | 2024-10-17 | 25,000 | $48.52 | $1.21M | 94,018 | SEC↗ |
| Thompson Tamar | Director | M Exercise deriv | 2024-10-07 | 2024-10-09 | 30,000 | — | $0 | 0 | SEC↗ |
| Thompson Tamar | Director | M Exercise | 2024-10-07 | 2024-10-09 | 30,000 | $27.63 | $828.9K | 30,000 | SEC↗ |
| Thompson Tamar | Director | S Sale | 2024-10-07 | 2024-10-09 | 30,000 | $44.98 | $1.35M | 0 | SEC↗ |
| Flanagan W. Michael | CSTO | M Exercise deriv | 2024-10-01 | 2024-10-03 | 62,500 | — | $0 | 25,000 | SEC↗ |
| Flanagan W. Michael | CSTO | M Exercise | 2024-10-01 | 2024-10-03 | 62,500 | $26.75 | $1.67M | 147,889 | SEC↗ |
| Flanagan W. Michael | CSTO | S Sale | 2024-10-01 | 2024-10-03 | 62,500 | $47.62 | $2.98M | 85,389 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | S Sale | 2024-09-23 | 2024-09-23 | 11,510 | $44.00 | $506.4K | 96,355 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2024-09-23 | 2024-09-23 | 32,880 | $44.00 | $1.45M | 234,663 | SEC↗ |
| Flanagan W. Michael | CSTO | S Sale | 2024-09-23 | 2024-09-23 | 11,847 | $43.89 | $520.0K | 85,389 | SEC↗ |
| Flanagan W. Michael | CSTO | S Sale | 2024-09-23 | 2024-09-23 | 13,153 | $44.00 | $578.7K | 72,718 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2024-09-23 | 2024-09-23 | 13,153 | $44.00 | $578.7K | 69,018 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise deriv | 2024-09-19 | 2024-09-20 | 5,000 | — | $0 | 8,323 | SEC↗ |
| LEVIN ARTHUR A | Director | S Sale | 2024-09-19 | 2024-09-20 | 5,000 | $45.73 | $228.6K | 14,830 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise | 2024-09-19 | 2024-09-20 | 5,000 | $1.24 | $6.2K | 19,830 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | A Award | 2024-09-19 | 2024-09-23 | 25,000 | — | $0 | 121,355 | SEC↗ |
| MacLean Michael F | Chief Financial Officer | A Award | 2024-09-19 | 2024-09-23 | 25,000 | — | $0 | 107,865 | SEC↗ |
| Boyce Sarah | President and CEO | A Award | 2024-09-19 | 2024-09-23 | 62,500 | — | $0 | 267,543 | SEC↗ |
| Boyce Sarah | President and CEO | A Award | 2024-09-19 | 2024-09-23 | 62,500 | — | $0 | 297,163 | SEC↗ |
| Flanagan W. Michael | CSTO | A Award | 2024-09-19 | 2024-09-23 | 25,000 | — | $0 | 85,871 | SEC↗ |
| Flanagan W. Michael | CSTO | A Award | 2024-09-19 | 2024-09-23 | 25,000 | — | $0 | 97,718 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | A Award | 2024-09-19 | 2024-09-23 | 25,000 | — | $0 | 82,171 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | A Award | 2024-09-19 | 2024-09-23 | 25,000 | — | $0 | 94,018 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise deriv | 2024-09-11 | 2024-09-13 | 25,000 | — | $0 | 132,500 | SEC↗ |
| Flanagan W. Michael | CSTO | M Exercise deriv | 2024-09-11 | 2024-09-13 | 34,000 | — | $0 | 110,000 | SEC↗ |
| Flanagan W. Michael | CSTO | M Exercise deriv | 2024-09-11 | 2024-09-13 | 62,500 | — | $0 | 87,500 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | S Sale | 2024-09-11 | 2024-09-13 | 25,000 | $40.40 | $1.01M | 57,171 | SEC↗ |
| McCarthy Teresa | Chief Human Resources Office | M Exercise | 2024-09-11 | 2024-09-13 | 25,000 | $14.22 | $355.5K | 82,171 | SEC↗ |
| Flanagan W. Michael | CSTO | S Sale | 2024-09-11 | 2024-09-13 | 14,894 | $40.40 | $601.7K | 60,871 | SEC↗ |
| Flanagan W. Michael | CSTO | S Sale | 2024-09-11 | 2024-09-13 | 34,000 | $40.40 | $1.37M | 75,765 | SEC↗ |
| Flanagan W. Michael | CSTO | M Exercise | 2024-09-11 | 2024-09-13 | 34,000 | $22.47 | $764.0K | 109,765 | SEC↗ |
| Flanagan W. Michael | CSTO | S Sale | 2024-09-11 | 2024-09-13 | 62,500 | $40.40 | $2.52M | 75,765 | SEC↗ |
| Flanagan W. Michael | CSTO | M Exercise | 2024-09-11 | 2024-09-13 | 62,500 | $26.75 | $1.67M | 138,265 | SEC↗ |
| LEVIN ARTHUR A | Director | G Gift | 2024-09-06 | 2024-09-10 | 22,500 | — | $0 | 131,372 | SEC↗ |
| LEVIN ARTHUR A | Director | G Gift | 2024-09-06 | 2024-09-10 | 22,500 | — | $0 | 22,500 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise deriv | 2024-08-19 | 2024-08-21 | 5,000 | — | $0 | 13,323 | SEC↗ |
| LEVIN ARTHUR A | Director | S Sale | 2024-08-19 | 2024-08-21 | 5,000 | $45.19 | $225.9K | 14,830 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise | 2024-08-19 | 2024-08-21 | 5,000 | $1.24 | $6.2K | 19,830 | SEC↗ |
| Boyce Sarah | President and CEO | M Exercise deriv | 2024-08-06 | 2024-08-07 | 28,000 | — | $0 | 461,015 | SEC↗ |
| Boyce Sarah | President and CEO | S Sale | 2024-08-06 | 2024-08-07 | 28,000 | $43.35 | $1.21M | 205,043 | SEC↗ |
| Boyce Sarah | President and CEO | M Exercise | 2024-08-06 | 2024-08-07 | 28,000 | $1.24 | $34.7K | 233,043 | SEC↗ |
| Moriarty John B | Chief Legal Officer | A Award deriv | 2024-08-01 | 2024-08-05 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Moriarty John B | Chief Legal Officer | A Award | 2024-08-01 | 2024-08-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise deriv | 2024-07-19 | 2024-07-23 | 5,000 | — | $0 | 18,323 | SEC↗ |
| LEVIN ARTHUR A | Director | S Sale | 2024-07-19 | 2024-07-23 | 5,000 | $45.01 | $225.1K | 14,830 | SEC↗ |
| LEVIN ARTHUR A | Director | M Exercise | 2024-07-19 | 2024-07-23 | 5,000 | $1.24 | $6.2K | 19,830 | SEC↗ |
| Boyce Sarah | President and CEO | M Exercise deriv | 2024-07-09 | 2024-07-11 | 28,000 | — | $0 | 489,015 | SEC↗ |
| Boyce Sarah | President and CEO | M Exercise | 2024-07-09 | 2024-07-11 | 28,000 | $1.24 | $34.7K | 233,043 | SEC↗ |